Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form ...

Medical Aesthetics Machine Market The growing popularity of non-invasive cosmetic procedures is a major driver of the Global Medical Aesthe ...

Sublingual Allergy Immunotherapy Market The rising of allergic diseases, such as allergic rhinitis and asthma, is a factor driving the grow ...

A £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

A research team at Umeå University has created advanced light-controlled tools that allow for precise regulation of proteins in real time within living cells.